📰 Generation Bio News
Generation Bio News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Generation Bio. Real-time updates on events, politics, business and more.
May 28, 2024
Shares of Generation Bio Co. (NASDAQ:GBIO – Get Free Report) have received a consensus recommendation of “Hold” from the six analysts that are covering the company, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 1-year price target […]
May 26, 2024
The global biotechnology market was valued at approximately $1.55 trillion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 13.96% from 2024 to 2030, reaching a staggering...
May 4, 2024
Moderna, Inc. beats earnings expectations. Reported EPS is $-3.07, expectations were $-3.56.
May 2, 2024
Reports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)Prepares for launches of RSV vaccine and Spikevax® 2024-2025 formula; reaffirms 2024 expected product sales of approximately $4 billionInitiated three new clinical studies evaluating Moderna's investigational...
May 2, 2024
MRNA earnings call for the period ending March 31, 2024.
May 2, 2024
MRNA earnings call for the period ending March 31, 2024.
May 1, 2024
Generation Bio Co. (NASDAQ:GBIO – Get Free Report) has earned an average rating of “Hold” from the six research firms that are currently covering the firm, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 1-year price target […]
April 26, 2024
EQS-News: BB BIOTECH AG / Key word: Interim Report BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates...
April 23, 2024
22.04.2024 - CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) - Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today announced that six abstracts highlighting ...
April 22, 2024
CAMBRIDGE, Mass., April 22, 2024 -- Generation Bio Co. a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today announced that six abstracts...